Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Assets: 2011-2025

Historic Return on Assets for Iovance Biotherapeutics (IOVA) over the last 6 years, with Sep 2025 value amounting to -0.44%.

  • Iovance Biotherapeutics' Return on Assets was N/A to -0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.44%, marking a year-over-year change of. This contributed to the annual value of -0.44% for FY2024, which is N/A change from last year.
  • Per Iovance Biotherapeutics' latest filing, its Return on Assets stood at -0.44% for Q3 2025, which was down 5.45% from -0.42% recorded in Q2 2025.
  • Iovance Biotherapeutics' 5-year Return on Assets high stood at -0.35% for Q1 2023, and its period low was -0.54% during Q1 2024.
  • For the 3-year period, Iovance Biotherapeutics' Return on Assets averaged around -0.44%, with its median value being -0.43% (2025).
  • Its Return on Assets has fluctuated over the past 5 years, first declined by 20bps in 2024, then rose by 15bps in 2025.
  • Quarterly analysis of 3 years shows Iovance Biotherapeutics' Return on Assets stood at -0.54% in 2023, then declined by 20bps to -0.54% in 2024, then grew by 15bps to -0.44% in 2025.
  • Its Return on Assets stands at -0.44% for Q3 2025, versus -0.42% for Q2 2025 and -0.40% for Q1 2025.